Targeted therapy brings rapid remission in child with SM-associated leukemia
The targeted therapy drug gemtuzumab ozogamicin successfully treated a young boy with SM-AHN who did not respond to conventional therapies.
The targeted therapy drug gemtuzumab ozogamicin successfully treated a young boy with SM-AHN who did not respond to conventional therapies.
A case report describes a patient who experienced two failed transcatheter aortic valve replacements, likely related to her underlying SM.
A man with systemic mastocytosis experienced a severe allergic reaction and eventually died after being stung by a wasp.
Duplex sequencing can reveal KIT mutations in a subset of patients with SM who do not have detectable mutations by ddPCR, a study found.
Results from a recent study could support more accurate diagnosis and future therapies in indolent systemic mastocytosis.
As fire ants spread to more areas, people with SM face a greater risk of severe allergic reactions from fire ant stings.
Non-white patients with systemic mastocytosis appear to have a longer diagnostic journey and a greater disease burden than white patients.
Scientists observed differences in bone marrow mast cell characteristics across different mast cell disorders.
A clinical trial is testing avapritinib and decitabine to improve outcomes for patients with SM and an associated blood cancer.
Research shows a possible link between cold urticaria and cold-induced anaphylaxis with systemic mastocytosis.